The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 710.50
Bid: 710.00
Ask: 711.00
Change: -1.50 (-0.21%)
Spread: 1.00 (0.141%)
Open: 716.00
High: 718.50
Low: 707.50
Prev. Close: 712.00
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tate & Lyle Completes Re-Alignment of Eaststarch Joint Venture

2 Nov 2015 13:22

2 November 2015 – Tate & Lyle PLC

Tate & Lyle completes re-alignment of Eaststarch joint venture

Tate & Lyle PLC (Tate & Lyle) announces that it has completed the transaction to re-align the Eaststarch corn wet milling joint venture in Europe with Archer Daniels Midland Company (ADM). The signing of the agreement to re-align Eaststarch was announced on 21 April 2015.

Following completion, Tate & Lyle has acquired full ownership of the more speciality-focused plant in Slovakia and exited the predominantly Bulk Ingredients plants in Bulgaria, Turkey and Hungary. Tate & Lyle has also received the cash consideration of €240 million. Customary working capital adjustments will be made in due course.

END

For more information contact Tate & Lyle PLC:

Christopher Marsh, VP, Investor and Media Relations

Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7796 192 688

Andrew Lorenz (FTI Consulting), Media Relations

Tel: +44 (0) 203 727 1323 or Mobile: +44 (0) 7775 641 807

About Tate & Lyle:

Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, with operations in over 30 locations worldwide.

Tate & Lyle operates through two global divisions, Speciality Food Ingredients and Bulk Ingredients, supported by our Innovation and Commercial Development and Global Operations groups. The Group's strategy is to become a leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving Bulk Ingredients for sustained cash generation to fuel this growth.

Speciality Food Ingredients consists of three platforms: Texturants, which includes speciality starches and stabilisers; Sweeteners, which comprises nutritive sweeteners and our range of no-calorie sweeteners including SPLENDA® Sucralose; and our Health and Wellness portfolio which includes speciality fibres and our salt-reduction offering. Additionally, our Food Systems business provides a wide variety of blended ingredient solutions.

Tate & Lyle Bulk Ingredients includes bulk sweeteners, industrial starches and fermentation products (primarily acidulants). Corn co-products from both divisions are primarily sold as animal feed.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2015, Tate & Lyle sales totalled £2.7 billion. For more information, please visit http://www.tateandlyle.com. SPLENDA® is a trademark of Heartland Consumer Products LLC.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151102005931/en/

Copyright Business Wire 2015

Date   Source Headline
20th Jan 20175:42 pmBUSTransaction in Own Shares
19th Jan 20175:51 pmBUSTransaction in Own Shares
18th Jan 20175:52 pmBUSTransaction in Own Shares
17th Jan 20175:39 pmBUSTransaction in Own Shares
16th Jan 20176:07 pmBUSTransaction in Own Shares
13th Jan 20176:13 pmBUSTransaction in Own Shares
13th Jan 20179:43 amBUSCommencement of Share Purchase Programme
4th Jan 20173:11 pmBUSDirector/PDMR Shareholding
4th Jan 20172:11 pmBUSDirector/PDMR Shareholding
4th Jan 201712:51 pmBUSBlock Listing Interim Review
15th Dec 20167:00 amBUSDirectorate change
1st Dec 20162:27 pmBUSTotal Voting Rights
30th Nov 20162:09 pmBUSAdditional Listing
23rd Nov 201610:06 amBUSDirector/PDMR Shareholding
10th Nov 20169:56 amBUSDirector/PDMR Shareholding
3rd Nov 20167:00 amBUSHalf-year Report
1st Nov 20164:34 pmBUSTotal Voting Rights
31st Oct 201610:23 amBUSDirector Declaration
26th Oct 201610:17 amBUSDirectorate Change
10th Oct 20169:44 amBUSDirector Declaration
3rd Oct 201610:34 amBUSTotal Voting Rights
1st Sep 201610:06 amBUSTotal Voting Rights
22nd Aug 20162:12 pmBUSDirector/PDMR Shareholding
12th Aug 201610:11 amBUSDirector/PDMR Shareholding
5th Aug 20163:20 pmBUSHolding(s) in Company
2nd Aug 20161:48 pmBUSDirector/PDMR Shareholding
1st Aug 20162:26 pmBUSTotal Voting Rights
27th Jul 20163:39 pmBUSDirector/PDMR Shareholding
26th Jul 201611:22 amBUSDirector/PDMR Shareholding
21st Jul 20164:52 pmBUSResult of AGM
21st Jul 20167:00 amBUSTrading Statement
1st Jul 20165:29 pmBUSBlock listing Interim Review
1st Jul 20163:37 pmBUSTotal Voting Rights
29th Jun 201611:44 amBUSDirector/PDMR Shareholding
28th Jun 201610:51 amBUSDirector/PDMR Shareholding
22nd Jun 20161:49 pmBUSDirector/PDMR Shareholding
20th Jun 20164:40 pmBUSAnnual Financial Report
17th Jun 201611:52 amBUSHolding(s) in Company
16th Jun 20164:40 pmBUSDirector/PDMR Shareholding
1st Jun 201610:17 amBUSTotal Voting Rights
26th May 20167:00 amBUSFinal Results
3rd May 20163:20 pmBUSHolding(s) in Company
5th Apr 20167:00 amBUSTrading Statement
1st Apr 20169:32 amBUSTotal Voting Rights
11th Mar 201610:00 amBUSDirectorate Change
2nd Mar 201611:37 amBUSDirector/PDMR Shareholding
12th Feb 20164:27 pmBUSDirector/PDMR Shareholding
11th Feb 20164:48 pmBUSDirector/PDMR Shareholding
11th Feb 20167:00 amBUSTrading Statement
14th Jan 20167:00 amBUSTate & Lyle Capital Markets Event

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.